Discover Great Companies Discover Great Clients
Popularity  1.6万   |   Followers  4   |   Likes  21 Claim this company

Professional agency for sales of domestic and international medical de

No.135 Xuhui District Popularity Ranking Shanghai City No.1 Veterinary Drugs No.3 Testing Kits No.3 Ti Wai Zhen Duan Shi Agents No.3 Diagnostics Services No.3 Testing Reagents No.4 He Suan Fen Zi Diagnostics No.4 Diagnostics Products No.4 Nucleic Acids No.4 Kits No.4 Wei Sheng Wu Xue No.6 Diagnostic Reagents No.6 He Gan Acids 副理事长单位 理事单位 市级专精特新中小企业 专精特新小巨人企业 省级高新技术企业 市级高新技术企业
More

Company Overview

  • Nature: State-owned Enterprise Size: 100-499 employees Founded: 35年
  • Industry: Pharmaceuticals/Bioengineering 、 Medical Devices/Instruments
  • Full name: Shanghai Jienuo Biotechnology Co., Ltd.。

Development Stage

  • Stage: 战略投资, 2亿人民币。
  • Ranking: Ranked #1 in Shanghai Veterinary Drugs Company by popularity Ranked #3 in Shanghai Testing Kits Company by popularity Ranked #3 in Shanghai Ti Wai Zhen Duan Shi Agents Company by popularity Ranked #3 in Shanghai Diagnostics Services Company by popularity
  • Honors: 副理事长单位 理事单位 According to algorithm
  • Salary: 55% of positions earn 8-15K, In 2026 vs last yeardecreased by 14%.。.
  • Recruiting: In 2026 vs 2025decreased by 60%.
  • Requirement: Education: 本科 leads with 72.5%. Experience: 不限 leads with 72.5%.
  • Region: Distributed across 2 regions, 上海: 50%, 北京: 20%, 石家庄: 5%, 南京: 2.5%.

About the Company

[Summary] Professional agency for sales of domestic and international medical de

Sinopharm Group Shanghai Jienuo Biotechnology Co., Ltd. (hereinafter referred to as "Shanghai Jienuo") is affiliated with China National Pharmaceutical Group Corporation (hereinafter referred to as "Sinopharm Group") and China National Biotec Group Company Limited (hereinafter referred to as "China Biotech"). It is a diagnostic reagent trading enterprise under China Biotech, specializing in agency sales of domestic and international medical devices and in vitro diagnostic reagents. The products it represents cover fields such as molecular diagnostics, microbiology, and immunology, with partners including multinational companies from North America, Europe, Japan, and other countries, as well as domestic manufacturers renowned in their fields.

The "13th Five-Year Plan" strategic planning of China Biotech prioritizes the development of six core segments: vaccines, blood products, animal vaccines, diagnostic reagents, medical aesthetics, and antibodies. Shanghai Jienuo's in vitro diagnostic reagents are one of the key segments in the "13th Five-Year Plan" and also the first enterprise leading the mixed-ownership reform of China Biotech, aiming to promote the rapid development of the diagnostic business through institutional and mechanism innovation. As the unified operation platform for the medical diagnostics segment in the biomedical and health industry planned by China Biotech, Shanghai Jienuo integrates trade, industry, and science, focusing on building sales networks and channels, driving industrial development through sales, and constructing a comprehensive industrial chain for the diagnostics segment through technology introduction and investment mergers and acquisitions. In 2017, Shanghai Jienuo successfully secured technology transfer licensing cooperation projects for the cervical cancer risk assessment methylation detection kit from the German company Oncgnostics GmbH and the 2SMART single-tube multiplex nucleic acid detection kit from the Dutch company PathoFinder. While acting as an agent for imported kits, it is also intensively preparing to build its own production facility to transform and localize these detection technologies, producing high-quality localized products to better serve public health.

The main agency products of Shanghai Jienuo include the Gyntect? cervical cancer risk assessment methylation detection kit, the PathoFinder 2SMART single-tube multiplex nucleic acid detection kit, the VerePLEX Biosystem multiplex microbial pathogen nucleic acid detection system, and MBL autoimmune diagnostic products. These products focus on multiplex detection of infectious disease pathogens and molecular diagnostics of tumors, serving major clinical hospitals, centers for disease control and prevention, inspection and quarantine bureaus, and government laboratories such as the Food and Drug Administration. Adhering to the corporate philosophy of "Caring for life, safeguarding health," Shanghai Jienuo positions its products in precision medicine, personalized medicine, and rapid and accurate detection, playing an active role in promoting people's health and industry development.

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

Jienuo Biotechnology Financing History (1 rounds)

Manage
战略投资
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Amount: 2亿人民币
  • Investor: 华盖资本

Jienuo Biotechnology How Fast Is Hiring Growing? (14 open positions)

Manage
?
Growth Rate
2026 vs 2025
  • 2025: Up 121%
  • 2024: Down 59%
  • 2023: Down 36%
  • 2022: Up 23%
Jienuo Biotechnology Year-by-Year Hiring:
* Hiring was generally low during 2020-2022 due to the pandemic
Note: How fast is hiring at Shanghai Jienuo Biotechnology Co., Ltd. growing? Jienuo Biotechnology2026: 21 openings (down 60%), 2025: 53 openings (up 121%), 2024: 24 openings (down 59%), 2023: 58 openings (down 36%), 2022: 90 openings (up 23%), 2021: 73 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Jienuo Biotechnology Master's Degree Job Demand Analysis

(More)
N/A
Growth Rate
Jienuo Biotechnology Master's Hiring by Year: 2024 — 1 more jobs than 2023
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at Shanghai Jienuo Biotechnology Co., Ltd. growing? Jienuo BiotechnologyMaster's recruitment over the years: 2024: 4 openings (down 59%), 2023: 3 openings (down 36%), 2022: 3 openings (up 23%), 2021: 2 openings.

Jienuo Biotechnology — What Are the Salaries Like? (40 records)

Manage
Jienuo Biotechnology Salary Overview
salary range: 3K - 50K, 55% of roles pay ¥8-15K
Note: salary statistics are based on 40 salary records from the past year and depend on the job sample. For reference only.
How is the salary at Shanghai Jienuo Biotechnology Co., Ltd.?Jienuo Biotechnology55% of positions earn 8-15K, Undergraduate salary: ¥。Shanghai salary ranking: #3835,经营管理类 average salary ¥17.9K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of Jienuo Biotechnology

(More)
Are salaries high at Shanghai Jienuo Biotechnology Co., Ltd.? We provide: Sales, 招商, 实验员, Finance Specialist, Marketing, 临床, Accountant, 协调员, Development Engineer, Technical Support, Mechanic, 检验, 注册总监, 注册经理, Electrical Engineer, Researcher, Hardware, 美编, Software Engineer, Software Developer. Click to view detailed salary analysis by job.

Job Category

  • 经营管理类
    42.5% of total 42.5%
  • 销售类
    37.5% of total 37.5%
  • 生物/制药/化工/环保类
    17.5% of total 17.5%
  • 质量管理类
    17.5% of total 17.5%

Education

  • 本科
    72.5% of total 72.5%
  • 大专
    27.5% of total 27.5%

Experience

  • 不限
    72.5% of total 72.5%
  • 3-5年
    25% of total 25%
  • 5-10年
    2.5% of total 2.5%
View Detailed Analysis

What does Shanghai Jienuo Biotechnology Co., Ltd. require? Who is Jienuo Biotechnology hiring? Jienuo Biotechnology recruitment: 经营管理类占比最多占42.5%,其次是销售类占37.5%. What education can get in at Jienuo Biotechnology? 本科占比最多占72.5%,其次是大专占27.5%. Work experience required at Jienuo Biotechnology? 不限占比最多占72.5%,其次是3-5年占25%. Where are the job locations at Jienuo Biotechnology? 上海占比最多占50%,其次是北京占20%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 16,496.263万(元)
Legal Representative: 夏小凯
Date Established:
Credit Code: 91310104MA1FR8RA5X
Registered Address: 上海市徐汇区枫林路450号3层西区308室

Partners & Suppliers

华大基因向上海捷诺生物科技股份有限公司采购核酸检测试剂盒等产品,构成关联交易。 Source
合作客户 分子诊断试剂销售

People who follow Jienuo Biotechnology also follow

Jienuo Biotechnology Competitors (Similar Companies)

“Your professional clinical medical laboratory nearby”
医药 生物制品 诊断试剂 生物医药
“Rapid test product R&D and manufacturer”
汽车零部件/配件 头枕 脚垫 汽车座椅
“A wholly-owned subsidiary of China Resources Double Crane, a pharmaceu”
“以科技及创新提高生命质量。”
体外诊断试剂 诊断试剂 诊断试剂生产 生物芯片
发动机 变速箱 生产 汽车产业链
“To develop high-quality biologics that are accessible and affordable f”
房地产 国企改革 房地产开发 实业投资
涂料 精细化工 聚合物 汽车涂料
网络 品牌传播 营销服务 广告
“Provider of regenerative medicine products, technologies, and services”
“Explore life, extend hope”
“A provincial high-tech enterprise specializing in the development, pro”

Discover Great Companies, Discover Great Clients

上海公司名录 上海“Xuhui District”公司名录 上海“生物科技/生物工程”公司名录 上海“抗体”公司名录 上海“体外诊断试剂”公司名录 上海“诊断试剂”公司名录 上海“生物医药”公司名录 附近的公司

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates